Evidence map›Paper›PMID 22079595›Full record

ArticleGastroenterology2012

Severe defects in absorptive ion transport in distal colons of mice that lack ClC-2 channels.

Marcelo A Catalán, Carlos A Flores, Mireya González-Begne, Yan Zhang, Francisco V Sepúlveda, James E Melvin

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Knockout of ClC-2 reveals critical functions of adherens junctions in colonic homeostasis and tumorigenicity.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  8. Research and progress on ClC‑2 (Review).Molecular medicine reports · 2017
    Review
  9. Review
  10. Article
  11. Opioid-induced constipation: advances and clinical guidance.Therapeutic advances in chronic disease · 2016
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Lubiprostone in constipation: clinical evidence and place in therapy.Therapeutic advances in chronic disease · 2015
    Review
  17. Article
  18. Chloride channelopathies of ClC-2.International journal of molecular sciences · 2013
    Review
  19. Article
  20. Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Marcelo A CatalánSecretory Mechanisms and Dysfunction Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA.
Carlos A Flores
Mireya González-Begne
Yan Zhang
Francisco V Sepúlveda
James E Melvin
Centro de Estudios Científicos · CLNational Institute of Dental and Craniofacial Research · USNational Institutes of Health · USUniversity of Rochester Medical Center · US

Funding

NIDCR DIR Secretory Mechanisms and Dysfunctions SectionZIADE000738 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MELVIN, JAMES · 2011 to 2019
$14.4M
MECHANISMS OF ANION TRANSPORT PROTEINS IN SALIVARY CELLSR01DE009692 · NIDCR · UNIVERSITY OF ROCHESTER · PI MELVIN, JAMES E · 1991 to 2010
$4.7M
Intramural NIH HHS Z99 DA999999Intramural NIH HHS Z99 DE999999Intramural NIH HHS Z99 OD999999NIDCR NIH HHS DE09621NIDCR NIH HHS R01 DE009692
6 · The paper itself

Abstract

BACKGROUND &

aimsThe fluid secretion model predicts that intestinal obstruction disorders can be alleviated by promoting epithelial Cl(-) secretion. The adenosine 3',5'-cyclic monophosphate (cAMP)-activated anion channel CFTR mediates Cl(-)-dependent fluid secretion in the intestine. Although the role of the ClC-2 channel has not been determined in the intestine, this voltage-gated Cl(-) channel might compensate for the secretory defects observed in patients with cystic fibrosis and other chronic constipation disorders. We investigated whether mice that lack ClC-2 channels (Clcn2(-/-)) have defects in intestinal ion transport.

methodsImmunolocalization and immunoblot analyses were used to determine the cellular localization and the amount of ClC-2 expressed in mouse early distal colon (EDC) and late distal colon (LDC). Colon sheets from wild-type and Clcn2(-/-) littermates were mounted in Ussing chambers to determine transepithelial bioelectrical parameters and Na(+), K(+), and Cl(-) fluxes.

resultsExpression of ClC-2 was higher in the basolateral membrane of surface cells in the EDC compared with the LDC, with little expression in crypts. Neither cAMP nor Ca(2+)-induced secretion of Cl(-) was affected in the EDC or LDC of Clcn2(-/-) mice, whereas the amiloride-sensitive short-circuit current was increased approximately 3-fold in Clcn2(-/-) EDC compared with control littermates. Conversely, electroneutral Na(+), K(+), and Cl(-) absorption was dramatically reduced in colons of Clcn2(-/-) mice.

conclusionsBasolateral ClC-2 channels are required for colonic electroneutral absorption of NaCl and KCl. The increase in the amiloride-sensitive short-circuit current in Clcn2(-/-) mice revealed a compensatory mechanism that is activated in the colons of mice that lack the ClC-2 channel.

Indexed as

Intestinal AbsorptionAnimalsBlotting, WesternChloride ChannelsChlorineCLC-2 Chloride ChannelsColonConstipationFemaleIntestinal MucosaIon TransportMaleMiceMice, KnockoutPolymerase Chain ReactionPotassium ChlorideChloride ChannelsChlorineCLC-2 Chloride ChannelsClcn2 protein, mousePotassium ChlorideSodium Chloride

Identifiers

PMID22079595
PMCPMC3267842
OpenAlexW2100914720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.